Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug patents in Japan

Executive Summary

Senate Commerce/Foreign Commerce Subcommittee, chaired by Sen. Rockefeller (DW. Va), is planning a hearing Feb. 28 on U.S. companies getting and enforcing patents in Japan. SmithKline's Alan Lourie is scheduled to testify, along with Michael Kirk, assistant commissioner for external affairs in the Commerce Department's Patent & Trademark Office, and A. E. Hirsch, representing the Pacific Industrial Property Association. Hearing will be held at 9:30 a.m. in SR-253, Russell Senate Office building.

You may also be interested in...



Coronavirus Update: Novavax Launches Phase III Trial In UK As Virus Surges Back

Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.

Alvotech And DKSH Extend Partnership For Six Biosimilars

Alvogen sister company Alvotech, is continuing to extend its network of commercial partners by expanding its partnership with DKSH, a Swiss market expansion services group, for the commercialization of six biosimilars in Asian markets.

UK To Diverge On Biosimilar Data Requirements

The UK regulator wants to be a “catalyst for change” in reducing regulatory burdens, saying that better regulation based on science is in everyone’s interest.

UsernamePublicRestriction

Register

PS122308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel